Repository of Research and Investigative Information

Repository of Research and Investigative Information

Baqiyatallah University of Medical Sciences

QSAR and QSTR study of selenocyanate derivatives to improve their therapeutic index as anti-leishmanial agents

(2014) QSAR and QSTR study of selenocyanate derivatives to improve their therapeutic index as anti-leishmanial agents. Medicinal Chemistry Research. pp. 818-826. ISSN 1054-2523

[img] Text
QSAR and QSTR study of selenocyanate derivatives to improve their therapeutic index as anti-leishmanial agents.pdf

Download (396kB)

Official URL: http://apps.webofknowledge.com/InboundService.do?F...

Abstract

Experimental data of selenocyanate derivatives show that they are potent inhibitors of Leishmania growth. In the current study, a series of selenocyanate derivatives were subjected to quantitative structure activity relationship and quantitative structure toxicity relationship analyses to identify the ideal physicochemical characteristics of potential anti-leishmanial activity with limited cytotoxic effects. Selenocyanate were built using HyperChem program, and conformational studies were performed through the semi-empirical method followed by the PM3 force field. Multi-linear regression was used as a chemo metric tool. The developed models were shown to be statistically significant according to the validation parameters. Based on our computational studies four descriptors, SPAM, P2e, B08 N-N and G2p can affect the activity and the cytotoxicity of selenocyanate derivatives.

Item Type: Article
Keywords: Cytotoxicity Leishmaniasis QSAR QSTR Selenocyanates cutaneous leishmaniasis design 1,4-dihydropyridines chemotherapy substituent Pharmacology & Pharmacy
Divisions:
Page Range: pp. 818-826
Journal or Publication Title: Medicinal Chemistry Research
Journal Index: ISI
Volume: 23
Number: 2
Identification Number: https://doi.org/10.1007/s00044-013-0610-8
ISSN: 1054-2523
Depositing User: مهندس مهدی شریفی
URI: http://eprints.bmsu.ac.ir/id/eprint/5872

Actions (login required)

View Item View Item